A detailed history of Summit Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Summit Financial, LLC holds 8,548 shares of AMGN stock, worth $2.26 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,548
Previous 6,137 39.29%
Holding current value
$2.26 Million
Previous $1.92 Million 43.66%
% of portfolio
0.11%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $745,915 - $813,423
2,411 Added 39.29%
8,548 $2.75 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $830,027 - $1.01 Million
3,159 Added 106.08%
6,137 $1.92 Million
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $1,344 - $1,622
5 Added 0.17%
2,978 $846,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $5,114 - $5,769
20 Added 0.68%
2,973 $856,000
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $739,911 - $918,620
-3,384 Reduced 53.4%
2,953 $793,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $204,627 - $241,968
955 Added 17.74%
6,337 $1.41 Million
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $55,544 - $67,699
246 Added 4.79%
5,382 $1.3 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $39,393 - $50,053
172 Added 3.46%
5,136 $1.35 Million
Q3 2022

Nov 15, 2022

BUY
$224.46 - $253.15 $251,844 - $284,034
1,122 Added 29.2%
4,964 $1.12 Billion
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $54,216 - $60,333
235 Added 6.52%
3,842 $934,000
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $99,329 - $109,884
453 Added 14.36%
3,607 $872,000
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $182,571 - $208,936
918 Added 41.06%
3,154 $709,000
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $230,525 - $270,088
1,086 Added 94.43%
2,236 $475,000
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $268,617 - $298,011
1,150 New
1,150 $280,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.